SPRYCEL®

SPRYCEL®, the SPRYCEL logo, and Access Support® are registered trademarks of Bristol-Myers Squibb Company... SPRYCEL® (dasatinib) is used to treat adults and children 1 year of age and older with newly diagnosed Ph+ CML (Philadelphia chromosome-positive chronic myeloid leukemia) in chronic phase. Please see Indication and Important Safety Information.

Also known as: Bristol-Myers Squibb Company